Vaccines
Process Development and Application Expertise

Conjugated Polysaccharide & Microbial

Vaccines & Viral Therapy Process:

Biopharmaceutical
Applications Guide

Innovative technologies and class leading services, to help you accelerate process development and achieve performance goals.

  • Maximize downstream recovery
  • Predictable scale up
  • Robust impurity removal
  • Patient safety and regulatory compliance

Downstream
Formulation

Downstream

Increase Process Recovery

Featured Solution

Watch our webinar:

Post conjugation TFF is required to remove impurities (unreacted polysaccharide and carrier protein). Limited availability of specific pore size membranes often leads to yield sacrifices in order to maintain the required purity, which can impact the reliability of vaccine supply.

Custom TFF membranes have been developed to suit this purification objective. Explore webinars, application notes and product information to see how we can help.


Associated Products: